Product Information
IBUPROFEN 600 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0472 per EA under NDC 64380080806. Its NADAC has been published 422 times since Sep 5, 2018.
FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380080806
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078329FDA Approved
2/5/2009
TE Code
AB
On Market Since
8/24/2018
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 600 MG TABLET has been published 422 times since Sep 5, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0472 per EA |
|---|---|
| All-time high | $0.0687 (Mar 11, 2020) |
| All-time low | $0.0428 (Jul 17, 2024) |
| 52-week high | $0.0482 |
| 52-week low | $0.0428 |
| Median price | $0.0560 |
| Average price | $0.0554 |
| Largest weekly change | +21.4% (Aug 21, 2024) |
| Weeks tracked | 422 |
| Tracking since | Sep 5, 2018 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IBUPROFEN 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 600 MG TABLET, manufactured by Strides Pharma Inc., is $0.0472 per EA (NDC 64380080806), effective Sep 30, 2026.
How has the price of IBUPROFEN 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 600 MG TABLET has held within roughly two percent of its current level. It has been tracked across 422 weekly CMS publications since Sep 5, 2018.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 600 MG TABLET?
Since Sep 5, 2018, the NADAC for IBUPROFEN 600 MG TABLET has ranged from a low of $0.0428 (Jul 17, 2024) to a high of $0.0687 (Mar 11, 2020), with a median of $0.0560 per EA.
Are there cheaper alternatives to IBUPROFEN 600 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 600 MG TABLET, is $0.0443 per EA — about 6% below IBUPROFEN 600 MG TABLET.
Who manufactures IBUPROFEN 600 MG TABLET?
IBUPROFEN 600 MG TABLET (NDC 64380080806) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.